Patent: 9,821,051
✉ Email this page to a colleague
Summary for Patent: 9,821,051
Title: | Reducing hospitalization in elderly influenza vaccine recipients |
Abstract: | Compared to an unadjuvanted vaccine, an adjuvanted influenza vaccine can reduce by almost a quarter the risk of hospitalization for respiratory illness (e.g. influenza and pneumonia) in elderly recipients. Thus the invention provides a method for immunizing an elderly subject by administering an adjuvanted influenza vaccine, whereby the subject\'s risk of hospitalization for respiratory illness (e.g. influenza and pneumonia) is reduced relative to an elderly subject who receives an unadjuvanted influenza vaccine. |
Inventor(s): | Groth; Nicola (Siena, IT) |
Assignee: | Seqirus UK Limited (Berkshire, GB) |
Application Number: | 13/279,156 |
Patent Claims: | see list of patent claims |
Details for Patent 9,821,051
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Seqirus Inc. | FLUAD | influenza vaccine, adjuvanted | Injection | 125510 | 11/24/2015 | ⤷ Try a Trial | 2030-10-28 |
Seqirus Inc. | FLUAD,FLUAD QUADRIVALENT | influenza vaccine, adjuvanted | Injection | 125510 | 02/21/2020 | ⤷ Try a Trial | 2030-10-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |